These results suggest that skeletal dysplasia especially the chondrodysplasia in fgfr3 mutants is associated with up-regulated Wnt/β-catenin signaling, which could be partially alleviated by inhibiting Wnt/β-catenin signaling. Here, FGFR3 is linked to skeletal dysplasia.